Asthma Clinical Trials

Find Asthma Clinical Trials Near You

A Multicentre Study to Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis

Status: Recruiting
Location: See all (25) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a multi-center study to explore the positive predictive value of bronchodilation test with portable oscillometry compared to either BDT or BPT with spirometry in asthma diagnosis and to compare it with bronchodilation with spirometry (the current gold standard). In the study, the target patients' profile is the suspected asthma patient with asthmatic symptoms (wheezing, shortness of breath, chest tightness, and/or cough) and aim to enroll 500 participants from 25 sites across different regions in China.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

⁃ Participants must meet all the following criteria and sign an informed consent form (ICF) to be eligible for the study.

• Patient must be aged 18-75 years old at the time of enrollment.

• Presented with asthmatic symptoms such as wheezing, shortness of breath, chest tightness and cough ≥2 months prior to enrollment (Day 0), with/without an established asthma diagnosis.

Locations
Other Locations
China
Research Site
RECRUITING
Beijing
Research Site
NOT_YET_RECRUITING
Cangzhou
Research Site
RECRUITING
Changsha
Research Site
NOT_YET_RECRUITING
Changsha
Research Site
NOT_YET_RECRUITING
Chengdu
Research Site
NOT_YET_RECRUITING
Chongqing
Research Site
RECRUITING
Guangzhou
Research Site
NOT_YET_RECRUITING
Guangzhou
Research Site
RECRUITING
Guangzhou
Research Site
NOT_YET_RECRUITING
Guangzhou
Research Site
NOT_YET_RECRUITING
Kunming
Research Site
RECRUITING
Quanzhou
Research Site
NOT_YET_RECRUITING
Shanghai
Research Site
NOT_YET_RECRUITING
Shanghai
Research Site
RECRUITING
Shanghai
Research Site
RECRUITING
Shanghai
Research Site
NOT_YET_RECRUITING
Suzhou
Research Site
RECRUITING
Taiyuan
Research Site
NOT_YET_RECRUITING
Tianjin
Research Site
RECRUITING
Ürümqi
Research Site
RECRUITING
Wuhan
Research Site
NOT_YET_RECRUITING
Xi'an
Research Site
NOT_YET_RECRUITING
Yangzhou
Research Site
RECRUITING
Zhengzhou
Research Site
RECRUITING
Zhuhai
Contact Information
Primary
AstraZeneca Clinical Study Information Center
information.center@astrazeneca.com
1-877-240-9479
Time Frame
Start Date: 2026-06-10
Estimated Completion Date: 2027-06-11
Participants
Target number of participants: 500
Treatments
Other: Pulmonary function Test intervention
enrollment 500 suspect asthma patients
Related Therapeutic Areas
Sponsors
Leads: AstraZeneca

This content was sourced from clinicaltrials.gov